Actinium Pharmaceuticals, Inc. Share Price
Equities
ATNM
US00507W2061
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.87 USD | +4.73% | +0.29% | +35.24% |
Sales 2024 * | 189K 15.09M | Sales 2025 * | 69.3M 5.53B | Capitalization | 205M 16.32B |
---|---|---|---|---|---|
Net income 2024 * | -59M -4.7B | Net income 2025 * | -2M -159M | EV / Sales 2024 * | 1,043 x |
Net cash position 2024 * | 7.22M 576M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.95 x |
P/E ratio 2024 * |
-3.67
x | P/E ratio 2025 * |
-40
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.84% |
1 day | +4.73% | ||
1 week | +0.29% | ||
Current month | -12.26% | ||
1 month | -12.26% | ||
3 months | +22.68% | ||
6 months | +27.22% | ||
Current year | +35.24% |
Managers | Title | Age | Since |
---|---|---|---|
Sandesh Seth
CEO | Chief Executive Officer | 60 | 29/02/12 |
Steve O'Loughlin
DFI | Director of Finance/CFO | 39 | 12/10/15 |
Akash Nahar
CTO | Chief Tech/Sci/R&D Officer | - | 26/10/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 07/11/13 | |
C. Nicholson
BRD | Director/Board Member | 68 | 31/12/07 |
Ajit Shetty
BRD | Director/Board Member | 77 | 27/03/17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 6.87 | +4.73% | 206,378 |
25/04/24 | 6.56 | -7.08% | 328,850 |
24/04/24 | 7.06 | +1.44% | 153,433 |
23/04/24 | 6.96 | -2.93% | 185,256 |
22/04/24 | 7.17 | +4.67% | 192,609 |
Delayed Quote Nyse, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.24% | 205M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+0.55% | 22.15B | |
-17.37% | 21.02B | |
-8.63% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ATNM Stock